152 related articles for article (PubMed ID: 36387200)
1. Significant response of pulmonary sarcomatoid carcinoma with obstructive atelectasis to treatment with the PD-1 inhibitor camrelizumab combined with transbronchial cryoablation: A case report and literature review.
Nian J; Zhu Y; Fu Q; Yang G; Wang X
Front Oncol; 2022; 12():1013047. PubMed ID: 36387200
[TBL] [Abstract][Full Text] [Related]
2. Anti-PD-1 antibody camrelizumab plus doxorubicin showed durable response in pulmonary sarcomatoid carcinoma: Case report and literature review.
Kong F; Wang W; Gong L; Wu W; Liu Y
J Clin Pharm Ther; 2020 Dec; 45(6):1489-1496. PubMed ID: 32776600
[TBL] [Abstract][Full Text] [Related]
3. Anlotinib combined with chemotherapy and immunotherapy for advanced pulmonary sarcomatoid cancer: a case report and literature review.
Piao MN; Ma XT; Tankere P; Liam CK; Li JL; Wang JP
Ann Transl Med; 2022 Sep; 10(18):1030. PubMed ID: 36267791
[TBL] [Abstract][Full Text] [Related]
4. Role of immunotherapy in pulmonary sarcomatoid carcinoma: review of current approaches and related biomarkers.
Ding K; Peng Z; Xu Y
Ther Adv Med Oncol; 2024; 16():17588359241249041. PubMed ID: 38716479
[TBL] [Abstract][Full Text] [Related]
5. A case report: A new promising treatment for pulmonary sarcomatoid carcinoma - Tislelizumab and Anlotinib combined with local radiotherapy.
Cai R; Liu Y; Sha H; Yu J; Fang Y; Zhou G; Shen B
Heliyon; 2023 Nov; 9(11):e21902. PubMed ID: 38027958
[TBL] [Abstract][Full Text] [Related]
6. Use of PD-1 inhibitor tislelizumab in the treatment of advanced pulmonary sarcomatoid carcinoma: A case report.
Xu L; Tao NN; Liang B; Li DW; Li HC; Su LL
Thorac Cancer; 2022 Feb; 13(3):502-505. PubMed ID: 34953097
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Advanced pulmonary sarcomatoid carcinoma with adrenal gland metastasis after sintilimab combined with anlotinib treatment.
Dai G; He L; Yan Q; Li Y; Huang Y; Li B; Wang G
Front Oncol; 2023; 13():1167516. PubMed ID: 37456237
[TBL] [Abstract][Full Text] [Related]
8. The treatment of advanced pulmonary sarcomatoid carcinoma.
Zheng Y; Fu Y; Zhong Q; Deng R; Zhang Y
Future Oncol; 2022 Feb; 18(6):727-738. PubMed ID: 34879738
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of advanced pulmonary sarcomatoid carcinoma with the PD-1 inhibitor toripalimab: A case report.
Jiao Y; Liu M; Luo N; Guo H; Li J
Oral Oncol; 2021 Jan; 112():104992. PubMed ID: 32943323
[TBL] [Abstract][Full Text] [Related]
10. Dramatic Response of Pulmonary Sarcomatoid Carcinoma to Nivolumab Combined with Anlotinib: A Case Report.
Jin C; Yang B
Case Rep Oncol; 2020; 13(2):601-605. PubMed ID: 32595469
[TBL] [Abstract][Full Text] [Related]
11. Significant benefits of pembrolizumab in treating refractory advanced pulmonary sarcomatoid carcinoma: A case report.
Chen P; Yu M; Zhang JL; Chen WY; Zhu L; Song Y; Jiang CY; Zhang S
World J Clin Cases; 2020 Jul; 8(13):2876-2884. PubMed ID: 32742998
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Multiple Primary Malignancies With PD-1 Inhibitor Camrelizumab: A Case Report and Brief Literature Review.
Wan Y; Wang Z; Yang N; Liu F
Front Oncol; 2022; 12():911961. PubMed ID: 35865468
[TBL] [Abstract][Full Text] [Related]
13. Synchronal pulmonary sarcomatoid carcinoma and lung adenocarcinoma EML4-ALK fusion: A case report.
Wang M; Gong Y; Cheng Y; Yang L; Wang W; Lei X
Oncol Lett; 2022 Oct; 24(4):343. PubMed ID: 36072009
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Multidomain Integrated Treatment Strategy
for Complex Primary Pulmonary Sarcomatoid Carcinoma].
Huo X; Zou H; Dong Y; Li Y; Bian L; Li L; Wang H
Zhongguo Fei Ai Za Zhi; 2024 Feb; 27(2):157-160. PubMed ID: 38453449
[TBL] [Abstract][Full Text] [Related]
15. Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review.
Wei Y; Wang L; Jin Z; Jia Q; Brcic L; Akaba T; Chu Q
Transl Lung Cancer Res; 2024 Mar; 13(3):635-653. PubMed ID: 38601447
[TBL] [Abstract][Full Text] [Related]
16. Anlotinib Combined With Chemotherapy for Recurrence of Pulmonary Sarcomatoid Cancer Previously Surgically Treated: A Case Report and Literature Review.
Li J; Liang H; He J; Sui X; Qin Y
Front Oncol; 2021; 11():639168. PubMed ID: 34046343
[TBL] [Abstract][Full Text] [Related]
17. [Current Status of Diagnosis and Treatment of Pulmonary Sarcomatoid Carcinoma].
Liu L; Zang R; Song P; Gao S
Zhongguo Fei Ai Za Zhi; 2018 Dec; 21(12):902-906. PubMed ID: 30591097
[TBL] [Abstract][Full Text] [Related]
18. Case Report: Pulmonary sarcomatoid carcinoma complicating TP53 mutation treated successfully with Tislelizumab combined with Anlotinib-a case report.
Li YF; Zhao XF; Tian Y; Xiao XY; Yan CY; Shen H
Front Genet; 2022; 13():949989. PubMed ID: 35938033
[TBL] [Abstract][Full Text] [Related]
19. Multimodality Treatment of Pulmonary Sarcomatoid Carcinoma: A Review of Current State of Art.
Zhang L; Lin W; Yang Z; Li R; Gao Y; He J
J Oncol; 2022; 2022():8541157. PubMed ID: 35368903
[TBL] [Abstract][Full Text] [Related]
20. Lazarus-type tumour response to therapy with nivolumab for sarcomatoid carcinomas of the lung.
Roesel C; Kambartel K; Kopeika U; Berzins A; Voshaar T; Krbek T
Curr Oncol; 2019 Apr; 26(2):e270-e273. PubMed ID: 31043837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
